These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 35959989)

  • 21. Rhinocerebral Mucormycosis in a COVID-19 Patient from Nepal: A Case Report.
    Kumar Gupta S; Jyotsana P; Singh A; Phuyal D; Allam P
    JNMA J Nepal Med Assoc; 2021 Jul; 59(239):703-705. PubMed ID: 34508493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19).
    Karimi-Galougahi M; Arastou S; Haseli S
    Int Forum Allergy Rhinol; 2021 Jun; 11(6):1029-1030. PubMed ID: 33713565
    [No Abstract]   [Full Text] [Related]  

  • 23. Mucormycosis in a patient with COVID-19 with uncontrolled diabetes.
    Shakir M; Maan MHA; Waheed S
    BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34326123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 Associated Mucormycosis: Ramping up our services during crisis.
    Xess I; Singh G; Yadav RK; Sachdev J; Pandey M
    Indian J Med Microbiol; 2022; 40(3):470-471. PubMed ID: 35379513
    [No Abstract]   [Full Text] [Related]  

  • 25. A case report of rhino-facial mucormycosis in a non-diabetic patient with COVID-19: a systematic review of literature and current update.
    Mohammadi F; Badri M; Safari S; Hemmat N
    BMC Infect Dis; 2021 Sep; 21(1):906. PubMed ID: 34479495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mucormycosis associated with COVID-19 in two kidney transplant patients.
    Arana C; Cuevas Ramírez RE; Xipell M; Casals J; Moreno A; Herrera S; Bodro M; Cofan F; Diekmann F; Esforzado N
    Transpl Infect Dis; 2021 Aug; 23(4):e13652. PubMed ID: 34038014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19-associated rhino-orbital-cerebral mucormycosis: A systematic review, meta-analysis, and meta-regression analysis.
    Bhattacharyya A; Sarma P; Kaur H; Kumar S; Bhattacharyya J; Prajapat M; Prakash A; Sharma S; Reddy DH; Thota P; Bansal S; Gautam BS; Medhi B
    Indian J Pharmacol; 2021; 53(6):499-510. PubMed ID: 34975140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exudative retinal detachment in COVID-19 - associated rhino-orbital mucormycosis - A rare clinical finding.
    Sarkar S; Gokhale T; Kaliaperumal S; Singh R; Begam RB; Deb AK
    Indian J Ophthalmol; 2021 Sep; 69(9):2535-2537. PubMed ID: 34427262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility of severe COVID-19 patients to rhino-orbital mucormycosis fungal infection in different clinical manifestations.
    Bayram N; Ozsaygılı C; Sav H; Tekin Y; Gundogan M; Pangal E; Cicek A; Özcan İ
    Jpn J Ophthalmol; 2021 Jul; 65(4):515-525. PubMed ID: 34057620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucormycosis after COVID-19 in a patient with diabetes.
    Chauhan K; Soni D; Sarkar D; Karuna T; Sharma B; Singh S; Karkhur S
    Lancet; 2021 Aug; 398(10301):e10. PubMed ID: 34363754
    [No Abstract]   [Full Text] [Related]  

  • 31. Mucormycosis in COVID-19: The Indian scenario.
    Ghosh R; Roy D; Benito-León J
    J Mycol Med; 2022 Aug; 32(3):101275. PubMed ID: 35364402
    [No Abstract]   [Full Text] [Related]  

  • 32. The "Black Turbinate" sign: An early MR imaging finding of nasal mucormycosis.
    Safder S; Carpenter JS; Roberts TD; Bailey N
    AJNR Am J Neuroradiol; 2010 Apr; 31(4):771-4. PubMed ID: 19942703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coronavirus disease-associated mucormycosis (CAM): A case control study during the outbreak in India.
    Wasiq M; K R; Gn A
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral mucormycosis in post-COVID-19 patients: A case series.
    Ahmed E; Abou-Bakr A; Hussein RR; El-Gawish AA; Ras AE; Ghalwash DM
    Oral Dis; 2022 Nov; 28 Suppl 2():2591-2592. PubMed ID: 34289206
    [No Abstract]   [Full Text] [Related]  

  • 35. Cerebral Mucormycosis in Context with COVID-19 Infection.
    Shastri M; Raval DM; Rathod VM
    J Assoc Physicians India; 2022 Aug; 70(8):11-12. PubMed ID: 36082737
    [No Abstract]   [Full Text] [Related]  

  • 36. Fatal allograft mucormycosis complicating severe COVID-19 infection and bacterial pyelonephritis.
    Chandra A; Rao S N; Malhotra KP
    Transpl Infect Dis; 2022 Apr; 24(2):e13793. PubMed ID: 35029013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Response to: COVID-19-associated mucormycosis and evolving evidence.
    Sarda R; Swain S; Ray A; Wig N
    QJM; 2022 Jun; 115(6):422. PubMed ID: 34264346
    [No Abstract]   [Full Text] [Related]  

  • 38. Commentary : Combating COVID-19-associated mucormycosis with limited resources.
    Kim U; Kulkarni P; Saini P
    Indian J Ophthalmol; 2022 Jun; 70(6):2169. PubMed ID: 35648005
    [No Abstract]   [Full Text] [Related]  

  • 39. The surge in Covid related mucormycosis.
    Chandra S; Rawal R
    J Infect; 2021 Sep; 83(3):381-412. PubMed ID: 34126158
    [No Abstract]   [Full Text] [Related]  

  • 40. Nasal Mucormycosis: Our experience with 24 cases.
    Bakshi SS; Das S; Ramesh S; Gopalakrishnan S
    Otolaryngol Pol; 2020 Feb; 74(4):37-40. PubMed ID: 32636347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.